Physician profile
Yu Cheng
NPI 1871127050
$960.67
in general payments reported to CMS, 2019-2025
9 companies · $703 in 2025
The $703 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $239 · 2022: $18.78 · 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $613 · Food and Beverage: $90.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $612.50 |
| Food and Beverage | $90.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $649.66 | 2025 | |
| Merz North America, INC. | $105.05 | 2021 | |
| Alexion Pharmaceuticals, INC. | $53.39 | 2025 | Ultomiris |
| Astrazeneca Pharmaceuticals Lp | $32.90 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $30.06 | 2021 | |
| Aurinia Pharma U.S., INC. | $29.82 | 2021 | |
| Amgen INC. | $23.49 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.78 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yu Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.